- Medically Reviewed by Mr Mfazo Hove Consultant Ophthalmologist
- Author: Chris Dunnington
- Published: September 6, 2025
- Last Updated: September 4, 2025
London's leading ophthalmic surgeon recognised by global industry leaders
Blue Fin Vision® Eye Clinic is delighted to announce that Mr Mfazo Hove, our founder and principal consultant ophthalmologist, has been selected as an invited speaker by ZEISS Medical Technology for the prestigious 43rd Congress of the European Society of Cataract and Refractive Surgeons (ESCRS) 2025.
This distinguished invitation recognises Mr Hove’s exceptional expertise and contributions to the field of ophthalmology, particularly in cataract surgery and premium intraocular lens implantation. The selection places him amongst a select group of global experts invited to share their clinical insights at one of the world’s most significant ophthalmic conferences.
International Recognition for Clinical Excellence
Mr Hove will present at the ZEISS booth in Copenhagen, Denmark, sharing his extensive experience with ZEISS intraocular lenses and their impact on patient outcomes. Speaking about his clinical experience, Mr Hove stated:
“I knew the AT LISA® tri lenses were good – my patients repeatedly told me. They have exceeded all my expectations since having them implanted 18 months ago. I might even have become a better surgeon – the numbers don’t lie. PC rupture 0.2% off 5,600 operations in 12 months down from 0.27%.”
This remarkable improvement in surgical outcomes demonstrates the tangible benefits that advanced lens technology brings to both surgeons and patients when combined with exceptional clinical expertise.
Event Details: Join Us for the Latest Clinical Updates
Join us for the latest clinical updates on ZEISS IOLs
Hear directly from the global experts about their latest clinical research and personal experiences in treating cataract patients with ZEISS intraocular lenses. It’s an event you don’t want to miss!
Location: Bella Center Copenhagen, Denmark
Date: September 13th, Saturday
Time: 10:00-10:30
Venue: Hall C, ZEISS Booth C1.130
This presentation forms part of ZEISS’s celebration of significant clinical milestones, including the company’s achievement of more than 10 million cataract surgeries conducted using their advanced lens technologies.
Blue Fin Vision®'s Commitment to Innovation
Mr Hove’s selection as an international speaker reinforces Blue Fin Vision®’s position at the forefront of ophthalmic innovation. Our clinic has consistently embraced cutting-edge technologies and surgical techniques to deliver superior outcomes for our patients.
The invitation to speak at ESCRS 2025 reflects our ongoing commitment to:
- Advanced surgical techniques that prioritise patient safety and optimal outcomes
- Premium intraocular lens technology that transforms patients’ quality of life
- Continuous innovation in surgical approaches and technology adoption
- International collaboration with leading industry partners
Setting New Standards in Cataract Surgery
The exceptional surgical outcomes referenced in Mr Hove’s presentation highlight the tangible benefits of combining surgical expertise with premium technology. A posterior capsule rupture rate of just 0.2% from 5,600 operations represents world-class performance that significantly exceeds international benchmarks.
These outcomes reflect:
- Meticulous surgical technique refined through thousands of procedures
- Careful patient selection and comprehensive pre-operative assessment
- Investment in the latest diagnostic and surgical technologies
- Commitment to continuous improvement and learning
Why This Matters for Our Patients
Mr Hove’s international recognition directly benefits patients at Blue Fin Vision® Eye Clinic. His insights from global collaboration and exposure to the latest innovations ensure our patients receive:
- World-class surgical expertise recognised by international peers
- Access to cutting-edge technology as soon as it becomes available
- Proven outcomes demonstrated through exceptional clinical results
- Continued innovation informed by global best practices
ZEISS Partnership: A Commitment to Excellence
Our partnership with ZEISS Medical Technology reflects Blue Fin Vision®’s unwavering commitment to providing the finest available treatments. ZEISS’s selection of Mr Hove as a clinical expert validates our approach to combining advanced technology with exceptional surgical skill.
This collaboration ensures our patients benefit from:
- Premium intraocular lenses with proven clinical outcomes
- State-of-the-art diagnostic and surgical equipment
- Ongoing training and development opportunities
- Access to emerging technologies before they reach the broader market
Looking Forward: Continued Leadership
Mr Hove’s presentation at ESCRS 2025 represents another milestone in Blue Fin Vision®’s journey of clinical excellence. As we continue to attract international recognition for our work, patients can be confident they are receiving care that sets global standards.
This achievement builds upon our recent recognition in the Spears 2025 Health & Wellness Index, where Mr Hove was acknowledged at the Top Recommended level for Opticians, Ophthalmologists and Laser Eye Surgeons Advisors.
Experience World-Class Care
The international recognition received by Mr Hove and Blue Fin Vision® demonstrates our commitment to delivering exceptional outcomes through advanced technology and surgical expertise. Our patients benefit from this global perspective, receiving care that incorporates the latest innovations and best practices from around the world.
Experience the difference that internationally recognised expertise makes. Contact Blue Fin Vision® Eye Clinic to discover how our award-winning care and cutting-edge technology can transform your vision and enhance your quality of life.
